Does nuchal translucency thickness in the first trimester predict GDM onset during pregnancy?

References

• Van Vugt JM, Tinnemans BW, Van Zalen-Sprock RM. Outcome and early childhood follow-up of chromosomally normal fetuses with increased nuchal translucency at 10–14 weeks of gestation. Ultrasound Obstet Gynecol 1998;11:388–390.
   Google Scholar
• Souka AP, Snidjers RJ, Novakov A, Soares W, Nicolaides KH. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10–14 weeks of gestation. Ultrasound Obstet Gynecol 1998;11:391–400.
   PubMed Web of Science ®Google Scholar
• Pajkrt E, Mol BWJ, Bleker OP, Bilardo CM. Pregnancy outcome and nuchal translucency measurements in fetuses with normal karyotype. Prenat Diagn 1999;19:1104–1108.
   Google Scholar
• Maymon R, Jauniaux E, Cohen O, Dreazen E, Weinraub Z, Herman A. Pregnancy outcome and and early childhood follow-up of fetuses with abnormally increased first trimester nuchal translucency. Hum Rep 2000;15:2023–2027.
   PubMed Web of Science ®Google Scholar
• Souka AP, Krampl E, Bakalis S, Heath V, Nicolaides KH. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound Obstet Gynecol 2001;18:9–17.
   PubMed Web of Science ®Google Scholar
• Hiippala A, Eronen M, Taipale P, Salonen R, Hiilesmaa V. Fetal nuchal translucency and normal chromosomes: a long follow-up study. Ultrasound Obstet Gynecol 2001;18:18–22.
   PubMed Web of Science ®Google Scholar
• Haak MC, Van Vugt JM. Pathophysiology of increased nuchal translucency: a review of the literature. Hum Rep 2003;9:175–184.
   Google Scholar
• L'Herminé-Coulomb A. Physiopathologie de la nuque épaisse. J Gynecol Obstet Biol Reprod 2005;34 (Suppl 1):2S89–2S96.
   Google Scholar
• Yuan SY, Breslin JW, Perrin R, Gaudreault N, Guo m, Kargozaran H, Wu MH. Microvascular permeability in diabetes and insuline resistance. Microcirculation 2007;14:363–373.
   Web of Science ®Google Scholar
• Feener EP, King GL. Endothelial dysfunction in diabetes mellitus: role in cardiovascular disease. Heart Fail Monit 2001;1:74–82.
   PubMedGoogle Scholar
• Moriguchi P, Sannomiya P, Lara PF, Oliveira-Filho RM, Greco KV, Sudo-Hayashi LS. Lymphatic system changes in diabetes mellitus: role of insulin and hyperglycemia. Diabetes Metab Res Rev 2005;21:150–157.
   PubMed Web of Science ®Google Scholar
• Allen VM, Armson BA, Wilson RD, Blight C, Gagnon A, Johnson JA, Langlois S, Summers A, Wyatt P, Farine D, et al. Teratogenity associated with pre-existing and gestational diabetes. J Obstet Gynecol Can 2007;29:927–944.
   PubMedGoogle Scholar
• Carpenter MW, Coustan DR. Criteria for screening test for gestational diabetes. Am J Obstet Gynecol 1982;157:758–763.
   Google Scholar
• Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshp-Conference on Gestational Diabetes Mellitus: the Organizing Committee. Diabetes Care 1998;21 (Suppl.2):B161–B167.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Gestational diabetes. Diabetes Care 2004;27 (Suppl.1):S88–S90.
   PubMed Web of Science ®Google Scholar
• Di Cianni G, Seghieri G, Lencioni C, Cuccuru I, Anichini R, De Bellis A, Ghio A, Tesi F, Volpe L, Del Prato S. Normal glucose tolerance and gestational diabetes mellitus. What is in between? Diabetes Care 2007;30:1783–1788.
   PubMed Web of Science ®Google Scholar
• King H. Epidemiology of glucose intolerance and gestational diabetes in women of childbearing age. Diabetes care 1998;21 (Suppl.2):B9–B13.
   Google Scholar
• Xiong X, Saunders F, Wang F, Demianczuk N. Gestational diabetes mellitus: prevalence, risk factors, maternal and fetal outcomes. Int J Gynecol Obst 2001;75:221–228.
   PubMed Web of Science ®Google Scholar
• Jimenez- Moleon J, Bueno-Cavanillas A, Luna del Castillo J, Garcia-Martin M, Lardelli-Claret P, Galvet-Vargas R. Prevalence of gestational diabetes mellitus: variations related to screening strategy used. Eur J Endocrinol 2002;146:831–837.
   Google Scholar
• Di Cianni G, Volpe L, Lencioni C, Miccoli R, Cuccuru I, Ghio A, Chatzianagnostou K, Bottone P, Teti G, Del Prato S, et al. Prevalence and risk factors for gestational diabetes assessed by universal screening. Diabetes Res Clin Pract 2003;62:131–137.
   PubMed Web of Science ®Google Scholar
• Lapolla A, Mazzon S, Marini S, Fedele D. A screening program for gestational diabetes in a north Mediterranean area. Diabetes Nutr Metab 1995;8:33–41.
   Google Scholar
• Wen SW, Liu S, Kramer MS. Impact of prenatal glucose screening on the diagnosis of gestational diabetes and on pregnancy outcomes. Am J Epidemiol 2000;152:1009–1014.
   PubMed Web of Science ®Google Scholar
• Di Cianni G, Volpe L, Casadidio I, Bottone P, Marselli L, Lencioni C, Boldrini A, Teti G, Del Prato S, Benzi L. Universal screening and intensive metabolic management of gestational diabetes: cost-effectiveness in Italy. Acta Daibetol 2002;39:69–73.
   PubMedGoogle Scholar
• Roberts RN, Moohan JM, Foo RL, Harley JM, Traub A, Hadden DR. Fetal outcome in mothers with impared glucose tolerance in pregnancy. Diabetes Med 1993;10:438–443.
   PubMedGoogle Scholar
• Aberg A, Rydhstroem H, Frid A. Impared glucose tolerance associated with adverse pregnancy outcome: a population-based study in southern Sweden. Am J Obstet Gynecol 2001;184:77–83.
   PubMedGoogle Scholar
• Langer O, Yogev Y, Most O, Xenakis EMJ. Gestational diabetes:the consequences of not treating. Am J Obstet Gynecol 2005;192:989–997.
   PubMed Web of Science ®Google Scholar
• Kelekci S, Yilmaz B, Savan K, Sonmez S. Can increased nuchal translucency in the first trimester of pregnancy predict gestational diabetes mellitus? J Obstet Gynecol 2005;25:579–582.
   PubMedGoogle Scholar
• Kuhl C. Etiology and pathogenesis of gestational diabetes. Diabetes Care 1998;21 (Suppl.2):B19–B26.
   PubMedGoogle Scholar
• Vanbergue A, Valat AS, Dufour P, Cazaubiel M, Fontaine P, Puech F. Physiopathologie du diabètes gestationnel. J Gynecol Biol Reprod 2002;31 (Suppl.6):4S3–4S10.
   Google Scholar